Skip to contentSkip to footer
Catalyst Health Ventures
Catalyst Health Ventures
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
1 800 458 56 97
Investor Portal
Catalyst Health Ventures
Investor Portal
Close
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
linkedin
Get in Touch
info@chv.vc
Our Address
129 South Street, 4th Floor,
Boston, MA 02111
Investor Portal
EpitelFebruary 13, 2025

Steve Pacelli Appointed CEO of Epitel, Inc.

EpitelJune 26, 2024

Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors

EpitelApril 23, 2024

Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection

EpitelMay 5, 2022

Epitel Has Found a New Way to Detect Seizures

EpitelFebruary 16, 2022

Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

Catalyst Health Ventures
Catalyst Health Ventures (CHV) is a venture capital firm investing in transformative medical technologies addressing global unmet needs.
Office

129 South Street, 4th Floor,
Boston, MA 02111

info@chv.vc

Links
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
Get In Touch
  • LinkedIn

© 2026 Catalyst Health Ventures. All Rights Reserved | Site By ConvyLab